These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5162365)

  • 21. Acute and chronic cardiovascular effects of hyperkalemia: new insights into prevention and clinical management.
    McCullough PA; Beaver TM; Bennett-Guerrero E; Emmett M; Fonarow GC; Goyal A; Herzog CA; Kosiborod M; Palmer BF
    Rev Cardiovasc Med; 2014; 15(1):11-23. PubMed ID: 24762462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-blockers do not protect against cardiac toxicity of hyperkalemia : Response to the article by Legrand et al. 'Association between hypo- and hyperkalemia and outcome in acute heart failure patients: the role of medications' [1].
    de Tymowski C; Atchade E; Montravers P; Provenchère S
    Clin Res Cardiol; 2018 Sep; 107(9):868-869. PubMed ID: 29532156
    [No Abstract]   [Full Text] [Related]  

  • 23. Insulin therapy in divided doses coupled with blood transfusion versus large bolus doses in patients at high risk for hyperkalemia during liver transplantation.
    Xia VW; Obaidi R; Park C; Braunfeld M; Neelakanta G; Nourmand H; Hu KQ; Steadman RH
    J Cardiothorac Vasc Anesth; 2010 Feb; 24(1):80-3. PubMed ID: 19362017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.
    Heerspink HJ; Gao P; de Zeeuw D; Clase C; Dagenais GR; Sleight P; Lonn E; Teo KT; Yusuf S; Mann JF
    Eur J Prev Cardiol; 2014 Mar; 21(3):299-309. PubMed ID: 24191305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PEARL-HF: prevention of hyperkalemia in patients with heart failure using a novel polymeric potassium binder, RLY5016.
    Buysse JM; Huang IZ; Pitt B
    Future Cardiol; 2012 Jan; 8(1):17-28. PubMed ID: 22185443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bilateral adrenalectomy for hypertensive vascular disease; hormonal requirements in the presence of renal insufficiency: body potassium in chronic hyperkalemia.
    MORSE WI; CRISCITIELLO MG; AMADOR E; RENOLD AE; HARRISON JH; DAMMIN GJ; THORN GW
    Am J Med; 1959 Feb; 26(2):315-23. PubMed ID: 13617287
    [No Abstract]   [Full Text] [Related]  

  • 27. Severe hyperkalemia in a case of chronic renal insufficiency.
    GEDGE SW; ANDERSON MW; BROADBENT JC
    Postgrad Med; 1962 Mar; 31():306-10. PubMed ID: 13897459
    [No Abstract]   [Full Text] [Related]  

  • 28. Combined therapy with captopril and potassium supplementation. A potential for hyperkalemia.
    Burnakis TG; Mioduch HJ
    Arch Intern Med; 1984 Dec; 144(12):2371-2. PubMed ID: 6391404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ACUTE RENAL FAILURE AFTER HEMOLYTIC TRANSFUSION REACTION.
    DOBERNECK RC; REISER MP; YUNIS E
    Surg Gynecol Obstet; 1964 Nov; 119():1069-73. PubMed ID: 14239289
    [No Abstract]   [Full Text] [Related]  

  • 30. Hyperkalemia and renal insufficiency: role of selective aldosterone deficiency and tubular unresponsiveness to aldosterone.
    Arruda JA; Batlle DC; Sehy JT; Roseman MK; Baronowski RL; Kurtzman NA
    Am J Nephrol; 1981; 1(3-4):160-7. PubMed ID: 6758577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ask the doctors. My potassium level is high, and my physician stopped the medication that has successfully controlled my blood pressure for years, lisinopril. What is the danger from high potassium, and why is lisinopril a problem?
    Lee T; Lee R
    Harv Heart Lett; 2012 Sep; 23(1):2. PubMed ID: 23101125
    [No Abstract]   [Full Text] [Related]  

  • 32. Do hemolyzed potassium specimens need to be repeated?
    Khodorkovsky B; Cambria B; Lesser M; Hahn B
    J Emerg Med; 2014 Sep; 47(3):313-7. PubMed ID: 24930444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New drugs to prevent and treat hyperkalemia.
    Lepage L; Desforges K; Lafrance JP
    Curr Opin Nephrol Hypertens; 2016 Nov; 25(6):524-528. PubMed ID: 27584929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of spironolactone in renal edema. Effectiveness and association with hyperkalemia.
    MANNING RT; BEHRLE FC
    JAMA; 1961 Jun; 176():769-71. PubMed ID: 13766245
    [No Abstract]   [Full Text] [Related]  

  • 35. Predictors of hyperkalemia and death in patients with cardiac and renal disease.
    Jain N; Kotla S; Little BB; Weideman RA; Brilakis ES; Reilly RF; Banerjee S
    Am J Cardiol; 2012 May; 109(10):1510-3. PubMed ID: 22342847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypokalemia and massive transfusion.
    Carmichael D; Hosty T; Kastl D; Beckman D
    South Med J; 1984 Mar; 77(3):315-7. PubMed ID: 6701617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of hyperkalemia risk following hypertension control with aldosterone blockade.
    Khosla N; Kalaitzidis R; Bakris GL
    Am J Nephrol; 2009; 30(5):418-24. PubMed ID: 19738369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is depletion of potassium in blood before transfusion essential?
    de Silva M; Seghatchian MJ
    Lancet; 1994 Jul; 344(8915):136. PubMed ID: 7912377
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical and electrophysiological consequences of hyperkalemia.
    Epstein M; Ketteler M
    Nephrol News Issues; 2016 Apr; 30(4):suppl 14-9. PubMed ID: 27254900
    [No Abstract]   [Full Text] [Related]  

  • 40. Potassium Chloride Sustained Release Dosing Pathway in an Academic Medical Center.
    Cook BM; Carter DM; Dell'Orfano H; Matta L
    Crit Pathw Cardiol; 2017 Dec; 16(4):158-160. PubMed ID: 29135624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.